What Is Disequilibrium Syndrome in Dialysis?

Dialysis is a life-sustaining treatment for kidney failure, removing waste products and excess fluid from the blood. While effective, the process can occasionally lead to a neurological complication known as Dialysis Disequilibrium Syndrome (DDS). DDS is a constellation of symptoms that occur during or shortly after a hemodialysis session, representing a temporary disturbance of the central nervous system. DDS is now considered uncommon due to modern protocols designed to mitigate its risk, especially in patients new to treatment. Understanding this syndrome involves recognizing its signs and the physiological changes that occur when blood chemistry is rapidly adjusted.

Defining Disequilibrium Syndrome

Disequilibrium Syndrome is a collection of neurological manifestations arising from the rapid clearance of solutes during dialysis. It is most frequently observed in patients receiving their initial hemodialysis treatments, when the body is vulnerable to sudden changes in blood chemistry. Patients with extremely high levels of waste products, specifically a high blood urea nitrogen (BUN) concentration, are also at increased risk. The syndrome can also affect chronic dialysis patients who have missed several treatments, allowing uremic toxins to build up. This condition is a clinical diagnosis, identified by its characteristic symptoms and timing rather than a specific laboratory test, and it primarily affects the brain.

The Underlying Physiological Mechanism

The primary cause of DDS is the “reverse urea effect,” resulting in an osmotic shift across the blood-brain barrier. Hemodialysis rapidly filters urea and waste products from the bloodstream, causing the solute concentration in the blood plasma to drop quickly. The blood-brain barrier limits the speed at which these solutes are removed from the brain tissue and cerebrospinal fluid (CSF), creating a temporary osmotic gradient. This gradient makes the solute concentration higher inside the brain than in the surrounding blood plasma, causing water to shift from the blood into the brain tissue. This influx leads to cerebral edema and increased intracranial pressure, which causes the neurological symptoms; “idiogenic osmoles” generated by the brain in response to chronic uremia further contribute to this effect.

Recognising the Signs and Symptoms

The clinical manifestations of DDS vary widely in severity, beginning during or immediately following the treatment. Mild symptoms are the most common and often include a persistent headache, nausea, vomiting, restlessness, muscle cramps, or mild confusion. These milder symptoms are often self-limited and may resolve within hours. In rare instances, DDS can progress to severe manifestations related to cerebral edema and elevated intracranial pressure. Severe symptoms include profound changes in mental status, such as somnolence or unresponsiveness, visual disturbances, tremors, seizures, or, in extreme cases, progression to a coma.

Prevention and Management Strategies

Clinical practice focuses on prevention, particularly when initiating dialysis in high-risk patients with elevated blood urea nitrogen levels. Medical staff use a gentle, gradual approach to the first few hemodialysis sessions to minimize rapid osmotic shifts. This preventive strategy involves starting with a low blood flow rate and limiting the duration of the initial treatment to ensure a slow and controlled reduction of urea. The intensity of the treatments is then gradually increased over subsequent sessions, allowing the body and brain time to adapt to the changing chemistry.

If symptoms of Disequilibrium Syndrome arise during a procedure, the immediate management involves slowing or temporarily stopping the dialysis session to halt rapid solute removal. For patients who develop severe symptoms, acute treatment focuses on quickly counteracting cerebral edema and reducing intracranial pressure. This is achieved by administering osmotic agents, such as mannitol or hypertonic saline, intravenously. These substances work by increasing the solute concentration in the blood, which draws the excess fluid back out of the swollen brain cells and into the bloodstream, correcting the osmotic imbalance.